Skip to content

Intestinal microecology-based early screening of colorectal tumors: a multi center clinical study

Intestinal microecology-based early screening of colorectal tumors: a multi center clinical study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057143
Enrollment
Unknown
Registered
2022-03-01
Start date
2022-03-25
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer and precancerous lesions

Interventions

Colorectal adenoma group:NA
Colorectal adenocarcinoma group:NA

Sponsors

Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40-79 years, no gender limit; 2. Patients diagnosed with colorectal polyps, adenoma, or adenocarcinoma by colonoscopy and histopathology, or healthy people without polyps by colonoscopy; 3. Volunteer to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardio-cerebrovascular, liver, kidney, hematopoietic system diseases, hyperthyroidism, diabetes and other serious primary diseases, or patients with serious diseases (such as tumors) and mental diseases that affect their survival; 2. Combined with other diseases that may affect intestinal microecology, such as inflammatory bowel disease, irritable bowel syndrome, malabsorption caused by short bowel syndrome, etc.; 3. Complicated with infectious diseases, such as AIDS, tuberculosis, viral hepatitis, etc.; 4. Had taken immunosuppressants, glucocorticoids, and non-steroidal anti-inflammatory drugs within 3 months before inclusion; Antibiotics, probiotics, prebiotics, etc., were taken within 1 month before inclusion in the study; They had taken proton pump inhibitors and bismuth-containing drugs within 2 weeks before inclusion in the study; 5. Suspected or confirmed history of alcohol and drug abuse; 6. Patients who are pregnant or trying to become pregnant or breast-feeding; 7. Patients after abdominal surgery (except appendicitis surgery); 8. Patients whose fecal microecological composition may be affected by various reasons were excluded, or were considered by the investigator to have inappropriate factors for inclusion.

Design outcomes

Primary

MeasureTime frame
Health /CRA classification diagnostic model based on microbial related markers;CRA/CRC classification and diagnosis model based on microbial related markers;

Secondary

MeasureTime frame
Characteristics and differences of gut microbiota;

Countries

China

Contacts

Public ContactHou Xiaohua

Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology

houxh@hust.edu.cn+86 13035143646

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026